Skip to main content


Editor Profiles

Akila Sridhar, Editor

Back to top

New Content ItemAkila Sridhar obtained her Ph.D from the University of Aberdeen, UK (funded by Cancer Research UK), has a further three years postdoctoral experience as an EMBO Long-term Fellow at Instituto Gulbenkian de Ciência (IGC), Portugal. Her interests cover biochemistry, molecular and mechanistic biology. After over eleven years of research experience, mainly as a molecular biologist, working with different model systems, she joined the BMC Series as a Locum Editor in September 2018. She has been the Editor of BMC Pharmacology and Toxicology since April 2019 and is based in Springer Nature’s London office.  

William Spenceley Jones, Assistant Editor

New Content ItemWilliam Spenceley Jones is an Assistant Editor for BMC Pharmacology and Toxicology. He graduated from Imperial College with a BSc in Biology, and his interests include developmental biology and genetics. He first joined springer Nature in 2017, working as a Publishing Assistant at Scientific Reports, before joining the BMC Series as an Assistant Editor in March 2019, and is based in Springer Nature’s London office.

Section Editors

Catherine Sherwin

Clinical PharmacologyNew Content Item

Dr. Catherine Sherwin is currently an Associate Professor and Chief of the Division of Clinical Pharmacology, Department of Pediatrics, at the University of Utah School of Medicine. She earned her PhD at the University of Otago, Dunedin School of Medicine, New Zealand in Paediatric Clinical Pharmacology in 2007. Dr. Sherwin has expertise and experience in the development of quantitative pharmacometric models for special populations such as neonates, children and pregnant women. Her projects have included basic studies using cell-line and animal models, analytical method development and clinical trials, all with a distinct emphasis on clinical pharmacology and toxicology. Dr. Sherwin joined the Editorial Board as an Associate Editor in 2013 and became a Section Editor for Clinical Pharmacology Section 2015.

Giorgio Palù

New Content ItemDrug design, discovery and delivery

Giorgio Palù has obtained his MD from the University of Padova, Italy, with a further Specialty Diplomas in Oncology and in General Pathology from the University of Pavia. He was a Postdoctoral fellow and Research associate first in Institut Bordet, Université Libre in Brussels and then at Chester Beatty Research Institute (London University, 1977-80) and Department of Pharmacology, Yale University,1980). He is currently a Full Professor and Chair of Microbiology and Virology, School of Medicine, Department of Molecular Medicine, University of Padova, Italy. His research interest includes diagnostic virology, molecular characterization and drug discovery. He joined BMC Pharmacology and Toxicology as an Associate Editor in 2014. He currently is the Section Editor of the Drug design, discovery and delivery n within the Journal.